Evaluation of a whole body vibration training on physical and psychological parameters of breast cancer patients with chemotherapy-induced peripheral neuropathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00018797

Enrollment

Registered

2019-11-06

Start date

2019-04-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 G62

Interventions

Group 1: Whole body vibration and gentle strength training Group 2: Gentle strength training Group 3: Control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Beginning of a chemotherapy treatment with cisplatin, paclitaxel or vinca alkaloids

Exclusion criteria

Exclusion criteria: acute infectious diseases, severe cardiac diseases (e.g. NYHA 3, myocardial infarction 3mg/d), severe neurological disorders, longstanding diabetes with neurological involvement, alcohol consumption with neurological sequelae, presence or suspected presence of a Korsakov syndrome, intended radiotherapy during the intervention

Design outcomes

Primary

Measure	Time frame
Symptomatic reduction of a chemotherapy-induced peripheral neuropathy	—

Secondary

Measure	Time frame
Balance, strength, quality of life, fatigue, depth sensitivity	—

Countries

Germany

Contacts

Public ContactThorsten Schmidt

Krebszentrum NordSupportivangebote Sport- und Bewegungstherapie

thorsten.schmidt@uksh.de+49 (0)431 50018205

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026